ProMIS Neurosciences Statistics
Share Statistics
ProMIS Neurosciences has 32.69M shares outstanding. The number of shares has increased by 73.09% in one year.
| Shares Outstanding | 32.69M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 9.38% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 22.93M |
| Failed to Deliver (FTD) Shares | 51 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 239.78K, so 0.73% of the outstanding shares have been sold short.
| Short Interest | 239.78K |
| Short % of Shares Out | 0.73% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 2.64 |
Valuation Ratios
The PE ratio is -0.81 and the forward PE ratio is -1.61.
| PE Ratio | -0.81 |
| Forward PE | -1.61 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 2.84 |
| P/FCF Ratio | -0.98 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ProMIS Neurosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.
| Current Ratio | 1.46 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 93.84 |
Financial Efficiency
Return on equity (ROE) is -3.52% and return on capital (ROIC) is -376.36%.
| Return on Equity (ROE) | -3.52% |
| Return on Assets (ROA) | -0.97% |
| Return on Capital (ROIC) | -376.36% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.92M |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -167.90K |
| Effective Tax Rate | 0.01 |
Stock Price Statistics
The stock price has increased by -67.26% in the last 52 weeks. The beta is 0.61, so ProMIS Neurosciences 's price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -67.26% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 46.11 |
| Average Volume (20 Days) | 71.05K |
Income Statement
| Revenue | n/a |
| Gross Profit | -10.44M |
| Operating Income | -18.90M |
| Net Income | -17.51M |
| EBITDA | -17.81M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.42 |
Balance Sheet
The company has 16.69M in cash and 0 in debt, giving a net cash position of 16.69M.
| Cash & Cash Equivalents | 16.69M |
| Total Debt | 0 |
| Net Cash | 16.69M |
| Retained Earnings | -123.84M |
| Total Assets | 24.51M |
| Working Capital | 21.88M |
Cash Flow
In the last 12 months, operating cash flow was -14.37M and capital expenditures 0, giving a free cash flow of -14.37M.
| Operating Cash Flow | -14.37M |
| Capital Expenditures | 0 |
| Free Cash Flow | -14.37M |
| FCF Per Share | -1.17 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -154.35% |
| FCF Yield | -47.77% |
Analyst Forecast
Currently there are no analyst rating for PMN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 28, 2022. It was a backward split with a ratio of 1:60.
| Last Split Date | Jun 28, 2022 |
| Split Type | backward |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | -4.83 |
| Piotroski F-Score | 2 |